CVRx, Inc. Operating Lease, Expense
CVRx, Inc. (CVRX) reported Operating Lease, Expense of $400.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2022-02-22
- CVRx, Inc. operating lease, expense for the quarter ending 2021-12-31 was $121.00K, a 2.42% decline year-over-year.
- CVRx, Inc. operating lease, expense for the quarter ending 2021-09-30 was $91.00K, a 1.11% increase year-over-year.
- CVRx, Inc. operating lease, expense for the quarter ending 2021-06-30 was $93.00K, a 1.06% decline year-over-year.
- CVRx, Inc. operating lease, expense for the quarter ending 2021-03-31 was $95.00K.
- CVRx, Inc. operating lease, expense for fiscal 2021 was $400.00K, a 0.00% change from fiscal 2020.
- CVRx, Inc. operating lease, expense for fiscal 2020 was $400.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2021-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $212.00K derived: sum of 2 quarters · filed 2022-02-22 | $305.00K derived: sum of 3 quarters · filed 2022-02-22 | $400.00K 10-K · filed 2022-02-22 |
| 2021-09-30 | $91.00K 10-Q · filed 2021-11-08 | $184.00K derived: sum of 2 quarters · filed 2021-11-08 | $279.00K 10-Q · filed 2021-11-08 | $403.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2021-06-30 | $93.00K 10-Q · filed 2021-08-09 | $184.00K 10-Q · filed 2021-08-09 | $312.00K derived: sum of 3 quarters · filed 2022-02-22 | $402.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2021-03-31 | $95.00K derived: 10-K 12 month − 3 quarters · filed 2022-02-22 | $219.00K derived: sum of 2 quarters · filed 2022-02-22 | $309.00K derived: sum of 3 quarters · filed 2022-02-22 | $403.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $214.00K derived: sum of 2 quarters · filed 2022-02-22 | $308.00K derived: sum of 3 quarters · filed 2022-02-22 | $400.00K 10-K · filed 2022-02-22 |
| 2020-09-30 | $90.00K 10-Q · filed 2021-11-08 | $184.00K derived: sum of 2 quarters · filed 2021-11-08 | $276.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $94.00K 10-Q · filed 2021-08-09 | $187.00K 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |